Adhera Therapeutics, Inc. Note Agreements

41 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Adhera Therapeutics, Inc. Original Issue Discount Senior Secured Promissory Note (June 2023)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Adhera Therapeutics, Inc. Original Issue Discount Senior Secured Promissory Note
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Adhera Therapeutics, Inc. Original Issue Discount Senior Secured Promissory Note
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Adhera Therapeutics, Inc. Original Issue Discount Senior Secured Promissory Note
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Adhera Therapeutics, Inc. Original Issue Discount Senior Secured Promissory Note
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Adhera Therapeutics, Inc. Original Issue Discount Senior Secured Promissory Note
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2023
Adhera Therapeutics, Inc. Original Issue Discount Senior Secured Promissory Note (May 2022)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2022
Form of Convertible Redeemable Promissory Note issued by Adhera Therapeutics, Inc. to select accredited investors on March 15, 2022
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2022
Adhera Therapeutics, Inc. 10% Convertible Redeemable Note Due October 7, 2022 (with Blue Lake Partners, LLC)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
FL
2021
Adhera Therapeutics, Inc. 10% Convertible Redeemable Note Due October 5, 2022 (Talos Victory Fund, LLC)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
MA
2021
Form of Convertible Promissory Note
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2021
Adhera Therapeutics Inc. 10% Convertible Redeemable Note Due June 25, 2022 (GS Capital Partners, LLC)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2021
Adhera Therapeutics Inc. 10% Convertible Redeemable Note Due August 9, 2022 (SE Holdings, LLC)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2021
Senior Secured Original Issue Discount Convertible Promissory Note between Adhera Therapeutics, Inc. and Pinz Capital Special Opportunities Fund LP
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2021
Senior Secured Original Issue Discount Convertible Promissory Note between Adhera Therapeutics, Inc. and Cavalry Fund I LP
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2021
Senior Secured Original Issue Discount Convertible Promissory Note between Adhera Therapeutics, Inc. and Cavalry Fund I LP
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2020
Senior Secured Original Issue Discount Convertible Promissory Note between Adhera Therapeutics, Inc. and Cavalry Fund I LP (June 26, 2020)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2020
Adhera Therapeutics, Inc. Original Issue Discount Convertible Promissory Note (February 2020)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2020
Adhera Therapeutics, Inc. 12% Secured Promissory Note (2019)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2019
Amendment to Convertible Promissory Note between Marina Biotech, Inc. and River Charitable Remainder Unit Trust (Isaac Blech, Trustee)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2017
Note Purchase Agreement between Marina Biotech, Inc. and River Charitable Remainder Unit Trust (November 22, 2017)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2017
Marina Biotech, Inc. $500,000 Convertible Promissory Note with River Charitable Remainder Unit Trust (November 22, 2017)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2017
Note Purchase Agreement between Marina Biotech, Inc. and Lenders (June 2017)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2017
Marina Biotech, Inc. Convertible Promissory Note (June 2017)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2017
Demand Promissory Note between Marina Biotech, Inc. and Autotelic Inc.
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2017
Demand Promissory Note between Marina Biotech, Inc. and Vuong Trieu for $540,000
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2016
Note Purchase Agreement between Marina Biotech, Inc. and Purchasers (June 20, 2016)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2016
Promissory Note between Marina Biotech, Inc. and Note Holder (June 2016)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2016
Sixth Amendment to Note and Warrant Purchase Agreement and Secured Promissory Notes among Marina Biotech, Inc., Subsidiaries, and Purchasers
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2014
Fourth Amendment to Note and Warrant Purchase Agreement and Secured Promissory Notes by Marina Biotech, Inc., MDRNA Research, Inc., Cequent Pharmaceuticals, Inc., and Purchasers
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2012
First Amendment to Note and Warrant Purchase Agreement and Secured Promissory Notes among Marina Biotech, Inc., Subsidiaries, and Purchasers
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2012
Note and Warrant Purchase Agreement among Marina Biotech, Inc., Subsidiaries, and Purchasers (February 10, 2012)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2012
15% Secured Promissory Note between Marina Biotech, Inc., Cequent Pharmaceuticals, Inc., MDRNA RESEARCH, Inc., and Holder
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2012
Promissory Note between MDRNA, Inc. and Cequent Pharmaceuticals, Inc. dated March 31, 2010
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
MA
2010
Note and Warrant Purchase Agreement among MDRNA, Inc., MDRNA Research, Inc., and Purchasers (December 22, 2009)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2009
12% Secured Promissory Note between MDRNA, Inc., MDRNA Research, Inc., and Holder (December 2009)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2009
Wells Fargo and Nastech Pharmaceutical $11,500,000 Revolving Line of Credit Note (October 20, 2004)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
DE
2004
Addendum to Promissory Note between Nastech Pharmaceutical Company Inc. and Wells Fargo Bank, N.A.
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2004
Wells Fargo $9,000,000 Revolving Line of Credit Note with Nastech Pharmaceutical Company Inc. (December 19, 2003)
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
WA
2004
Addendum to Promissory Note between Nastech Pharmaceutical Company Inc. and Wells Fargo Bank, N.A.
Note Agreements
Adhera Therapeutics, Inc.
Biotechnology
2003